Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06172335
NA

Effects of Cetoleic Acid on Atherosclerosis (Ketolinsyre's Effekt på Aterosklerose)

Sponsor: Oslo University Hospital

View on ClinicalTrials.gov

Summary

In this Randomized Controlled Trial (RCT) we want to study the effect of an oil with high concentrations of cetoelic acid (C22:n1-11) (intervention) compared to supplements with a low concentration of cetoleic acid (control), but with equivalent content of EPA og DHA, on plasma levels of epa and dha as well as atherosclerotic markers, glucose, c-peptide and triglycerides in a patient group with a metabolically unfavorable phenotype. Our primary endpoints are changes in the concentration of EPA and DHA in plasma.

Official title: Effects of Ketolic Acid on Atherosclerosis Markers in High-risk Patients With Metabolic Syndrome (Effekt av Ketolinsyre på aterosklerosemarkører i høyrisikopasienter Med Metabolsk Syndrom)

Key Details

Gender

All

Age Range

20 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

70

Start Date

2024-01-03

Completion Date

2027-12-31

Last Updated

2025-01-16

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Cetoleic acid

Very long monounsaturated fatty acid (C22:1n-11)

DIETARY_SUPPLEMENT

Control oil

Mix of oils with low cetoleic acid content

Locations (1)

Oslo University Hospital

Oslo, Norway